The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening

Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fetal diagnosis and therapy 2002-01, Vol.17 (1), p.17-21
Hauptverfasser: Tišlarić, Dubravka, Brajenović-Milić, Bojana, Ristić, Smiljana, Latin, Višnja, Žuvić-Butorac, Marta, Bačić, Josip, Petek, Marijan, Kapović, Miljenko
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 21
container_issue 1
container_start_page 17
container_title Fetal diagnosis and therapy
container_volume 17
creator Tišlarić, Dubravka
Brajenović-Milić, Bojana
Ristić, Smiljana
Latin, Višnja
Žuvić-Butorac, Marta
Bačić, Josip
Petek, Marijan
Kapović, Miljenko
description Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p < 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p < 0.001) and nonsmokers (p < 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.
doi_str_mv 10.1159/000047999
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1159_000047999</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71410599</sourcerecordid><originalsourceid>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</originalsourceid><addsrcrecordid>eNpt0E9LHDEYBvBQlKqrh54LEgoVPIzNO8nMJMei9Q-stLDrechm3ui4M8ma7FD25tfo1-snaeouLoi5JIff--bhIeQTsDOAQn1j6YhKKfWB7IPIIVOqFDvpzaDIuOTVHjmI8TEpWfHyI9kDkIznwPbJdPqA9MbZbkBnkHpLJ72ft-6eatfQXzq0yxX1jk4wDD291WGOIVLrA73wv93f5z-RTlauCb5HOjEB0aXZQ7JrdRfxaHOPyN3lj-n5dTb-eXVz_n2cGS6LZSY0L2XDINeIDJjmmtnCYolG6VwrgzlIgQ3OBJeqlBIBGjGzjBujUBQzPiIn672L4J8GjMu6b6PBrtMO_RDrCgSwQqkEv7yBj34ILmWr8zznlaqYSOh0jUzwMQa09SK0vQ6rGlj9v-f6tedkjzcLh1mPzVZuik3g6wboaHRng3amjVvHRVUyBttkcx3uMbyCy4vpy0_1orEJfX4XrbP8A0NemQ4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>222379704</pqid></control><display><type>article</type><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><source>Karger Journal Archive Collection</source><source>MEDLINE</source><source>Karger Journals</source><source>Alma/SFX Local Collection</source><creator>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</creator><creatorcontrib>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</creatorcontrib><description>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p &lt; 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p &lt; 0.001) and nonsmokers (p &lt; 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</description><identifier>ISSN: 1015-3837</identifier><identifier>EISSN: 1421-9964</identifier><identifier>DOI: 10.1159/000047999</identifier><identifier>PMID: 11803210</identifier><language>eng</language><publisher>Basel, Switzerland: Karger</publisher><subject>Adolescent ; Adult ; alpha-Fetoproteins - analysis ; Biological and medical sciences ; Biomarkers - blood ; Chorionic Gonadotropin, beta Subunit, Human - blood ; Chromosome aberrations ; Down Syndrome - diagnosis ; Female ; Gynecology. Andrology. Obstetrics ; Humans ; Management. Prenatal diagnosis ; Mass Screening ; Medical genetics ; Medical sciences ; Middle Aged ; Parity ; Pregnancy - blood ; Pregnancy Trimester, Second ; Pregnancy. Fetus. Placenta ; Prenatal Diagnosis ; Smoking</subject><ispartof>Fetal diagnosis and therapy, 2002-01, Vol.17 (1), p.17-21</ispartof><rights>2002 S. Karger AG, Basel</rights><rights>2002 INIST-CNRS</rights><rights>Copyright 2002 S. Karger AG, Basel</rights><rights>Copyright (c) 2002 S. Karger AG, Basel</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</citedby><cites>FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,2422,4009,27902,27903,27904</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13476001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11803210$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tišlarić, Dubravka</creatorcontrib><creatorcontrib>Brajenović-Milić, Bojana</creatorcontrib><creatorcontrib>Ristić, Smiljana</creatorcontrib><creatorcontrib>Latin, Višnja</creatorcontrib><creatorcontrib>Žuvić-Butorac, Marta</creatorcontrib><creatorcontrib>Bačić, Josip</creatorcontrib><creatorcontrib>Petek, Marijan</creatorcontrib><creatorcontrib>Kapović, Miljenko</creatorcontrib><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><title>Fetal diagnosis and therapy</title><addtitle>Fetal Diagn Ther</addtitle><description>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p &lt; 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p &lt; 0.001) and nonsmokers (p &lt; 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</description><subject>Adolescent</subject><subject>Adult</subject><subject>alpha-Fetoproteins - analysis</subject><subject>Biological and medical sciences</subject><subject>Biomarkers - blood</subject><subject>Chorionic Gonadotropin, beta Subunit, Human - blood</subject><subject>Chromosome aberrations</subject><subject>Down Syndrome - diagnosis</subject><subject>Female</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Humans</subject><subject>Management. Prenatal diagnosis</subject><subject>Mass Screening</subject><subject>Medical genetics</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Parity</subject><subject>Pregnancy - blood</subject><subject>Pregnancy Trimester, Second</subject><subject>Pregnancy. Fetus. Placenta</subject><subject>Prenatal Diagnosis</subject><subject>Smoking</subject><issn>1015-3837</issn><issn>1421-9964</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpt0E9LHDEYBvBQlKqrh54LEgoVPIzNO8nMJMei9Q-stLDrechm3ui4M8ma7FD25tfo1-snaeouLoi5JIff--bhIeQTsDOAQn1j6YhKKfWB7IPIIVOqFDvpzaDIuOTVHjmI8TEpWfHyI9kDkIznwPbJdPqA9MbZbkBnkHpLJ72ft-6eatfQXzq0yxX1jk4wDD291WGOIVLrA73wv93f5z-RTlauCb5HOjEB0aXZQ7JrdRfxaHOPyN3lj-n5dTb-eXVz_n2cGS6LZSY0L2XDINeIDJjmmtnCYolG6VwrgzlIgQ3OBJeqlBIBGjGzjBujUBQzPiIn672L4J8GjMu6b6PBrtMO_RDrCgSwQqkEv7yBj34ILmWr8zznlaqYSOh0jUzwMQa09SK0vQ6rGlj9v-f6tedkjzcLh1mPzVZuik3g6wboaHRng3amjVvHRVUyBttkcx3uMbyCy4vpy0_1orEJfX4XrbP8A0NemQ4</recordid><startdate>200201</startdate><enddate>200201</enddate><creator>Tišlarić, Dubravka</creator><creator>Brajenović-Milić, Bojana</creator><creator>Ristić, Smiljana</creator><creator>Latin, Višnja</creator><creator>Žuvić-Butorac, Marta</creator><creator>Bačić, Josip</creator><creator>Petek, Marijan</creator><creator>Kapović, Miljenko</creator><general>Karger</general><general>S. Karger AG</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>200201</creationdate><title>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</title><author>Tišlarić, Dubravka ; Brajenović-Milić, Bojana ; Ristić, Smiljana ; Latin, Višnja ; Žuvić-Butorac, Marta ; Bačić, Josip ; Petek, Marijan ; Kapović, Miljenko</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c385t-4a368d012aee010a3a0f5fe6ec9a2a9ce2184edeb4389688e11d4bf03cc9e45b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>alpha-Fetoproteins - analysis</topic><topic>Biological and medical sciences</topic><topic>Biomarkers - blood</topic><topic>Chorionic Gonadotropin, beta Subunit, Human - blood</topic><topic>Chromosome aberrations</topic><topic>Down Syndrome - diagnosis</topic><topic>Female</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Humans</topic><topic>Management. Prenatal diagnosis</topic><topic>Mass Screening</topic><topic>Medical genetics</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Parity</topic><topic>Pregnancy - blood</topic><topic>Pregnancy Trimester, Second</topic><topic>Pregnancy. Fetus. Placenta</topic><topic>Prenatal Diagnosis</topic><topic>Smoking</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tišlarić, Dubravka</creatorcontrib><creatorcontrib>Brajenović-Milić, Bojana</creatorcontrib><creatorcontrib>Ristić, Smiljana</creatorcontrib><creatorcontrib>Latin, Višnja</creatorcontrib><creatorcontrib>Žuvić-Butorac, Marta</creatorcontrib><creatorcontrib>Bačić, Josip</creatorcontrib><creatorcontrib>Petek, Marijan</creatorcontrib><creatorcontrib>Kapović, Miljenko</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Fetal diagnosis and therapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tišlarić, Dubravka</au><au>Brajenović-Milić, Bojana</au><au>Ristić, Smiljana</au><au>Latin, Višnja</au><au>Žuvić-Butorac, Marta</au><au>Bačić, Josip</au><au>Petek, Marijan</au><au>Kapović, Miljenko</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening</atitle><jtitle>Fetal diagnosis and therapy</jtitle><addtitle>Fetal Diagn Ther</addtitle><date>2002-01</date><risdate>2002</risdate><volume>17</volume><issue>1</issue><spage>17</spage><epage>21</epage><pages>17-21</pages><issn>1015-3837</issn><eissn>1421-9964</eissn><abstract>Objective: To evaluate the impact of smoking and number of previous births on maternal serum levels of α-fetoprotein and free β-subunit of human chorionic gonadotropin (free β-hCG). Methods: The study included 3,252 completed unaffected singleton pregnancies that proceeded beyond 37 weeks’ gestation and resulted with a birth of healthy child. Smoking status of mothers and data concerning gravidity and parity were collected at the sampling date. Serum markers were measured between 13 and 22 gestational weeks, corrected for maternal weight, and converted to multiples of median (MoM) for unaffected pregnancy of the corresponding gestational age. Median MoM values for both markers were examined in relation to both: smoking habits and number of previous births. Results: Smokers had significantly decreased free β-hCG MoM values compared to nonsmokers (p &lt; 0.001). The median levels showed a negative relationship with the number of previous births. The significance of a decreasing trend was proved, both in smokers (p &lt; 0.001) and nonsmokers (p &lt; 0.001). The median maternal serum α-fetoprotein MoM values did not show any significant dependence, neither with regard to smoking (p = 0.65) nor with regard to parity (p = 0.07). Conclusions: The recommendable adjustment of serum markers to smoking habits, especially concerning the free β-hCG levels, would be worthwhile. The evidence of the coexisting influence of parity on serum levels of free β-hCG, both in smokers and nonsmokers, should perhaps be a stimulus for reconsideration of which corrections the screening performance is dependent on.</abstract><cop>Basel, Switzerland</cop><pub>Karger</pub><pmid>11803210</pmid><doi>10.1159/000047999</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1015-3837
ispartof Fetal diagnosis and therapy, 2002-01, Vol.17 (1), p.17-21
issn 1015-3837
1421-9964
language eng
recordid cdi_crossref_primary_10_1159_000047999
source Karger Journal Archive Collection; MEDLINE; Karger Journals; Alma/SFX Local Collection
subjects Adolescent
Adult
alpha-Fetoproteins - analysis
Biological and medical sciences
Biomarkers - blood
Chorionic Gonadotropin, beta Subunit, Human - blood
Chromosome aberrations
Down Syndrome - diagnosis
Female
Gynecology. Andrology. Obstetrics
Humans
Management. Prenatal diagnosis
Mass Screening
Medical genetics
Medical sciences
Middle Aged
Parity
Pregnancy - blood
Pregnancy Trimester, Second
Pregnancy. Fetus. Placenta
Prenatal Diagnosis
Smoking
title The Influence of Smoking and Parity on Serum Markers for Down’s Syndrome Screening
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T14%3A00%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Influence%20of%20Smoking%20and%20Parity%20on%20Serum%20Markers%20for%20Down%E2%80%99s%20Syndrome%20Screening&rft.jtitle=Fetal%20diagnosis%20and%20therapy&rft.au=Ti%C5%A1lari%C4%87,%20Dubravka&rft.date=2002-01&rft.volume=17&rft.issue=1&rft.spage=17&rft.epage=21&rft.pages=17-21&rft.issn=1015-3837&rft.eissn=1421-9964&rft_id=info:doi/10.1159/000047999&rft_dat=%3Cproquest_cross%3E71410599%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=222379704&rft_id=info:pmid/11803210&rfr_iscdi=true